Sonoma Pharmaceuticals, Inc.
(NASDAQ : SNOA)

( )
SNOA After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
AMRNAmarin Corporation Plc Sponsored ADR
-5.84%19.822.0%$228.86m
SHPGShire PLC Sponsored ADR
0.91%181.950.4%$209.29m
JAZZJazz Pharmaceuticals Plc
2.04%148.542.2%$105.44m
PRGOPerrigo Co. Plc
2.29%65.546.8%$105.36m
ENDPEndo International Plc
-2.30%13.188.9%$68.17m
GWPHGW Pharmaceuticals PLC Sponsored ADR
-2.58%134.326.3%$67.31m
SAGESAGE Therapeutics, Inc.
-7.26%121.449.6%$56.52m
MNKMallinckrodt Plc
2.27%31.5921.1%$56.27m
ICPTIntercept Pharmaceuticals, Inc.
-7.39%100.7718.7%$50.12m
HZNPHorizon Pharma plc
-2.47%21.747.4%$46.63m
UTHRUnited Therapeutics Corporation
-2.27%111.7914.4%$44.09m
PTLAPortola Pharmaceuticals, Inc.
-7.02%20.417.7%$37.14m
ICLRICON Plc
-0.32%138.024.1%$35.03m
CTLTCatalent Inc
1.23%37.972.4%$34.37m
AERIAerie Pharmaceuticals, Inc.
-6.51%44.656.9%$29.04m

Company Profile

Sonoma Pharmaceuticals, Inc. engages in identifying, developing, and commercializing therapies for chronic skin conditions. It offers solutions in dermatology, animal healthcare, and advanced tissue care product areas. Its products target skin diseases including acne, atopic dermatitis, scarring, infections, itch, pain, and harmful inflammatory responses. The company was founded by Hojabr Alimi and Linda Alimi in April 1999 and is headquartered in Petaluma, CA.